NCT04295395

Brief Summary

This study evaluates the brain and renal oxygenation using near infrared spectroscopy in preterm infants with persistent ductus arteriosus

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2017

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 4, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

January 4, 2023

Status Verified

March 1, 2021

Enrollment Period

4.1 years

First QC Date

February 19, 2020

Last Update Submit

January 3, 2023

Conditions

Keywords

near-infrared spectroscopypreterm infantechocardiography

Outcome Measures

Primary Outcomes (1)

  • Differences of the mean values of regional oxygenation of the brain and renal

    Cerebral and renal regional tissue oxygen saturation monitoring on the day after echocardiography was done

    from Day 4 of live up to 36 weeks

Study Arms (3)

group1

preterm infant with closed ductus arteriosus, \<32 weeks birth weight \< 1500g, and \> 72 hours of age

Device: NONIN SenSmart model X-100 near- infrared spectrometer

group2

preterm infant with PDA \< 32 weeks, birth weight \< 1500g, and \> 72 hours of age

Device: NONIN SenSmart model X-100 near- infrared spectrometer

group3

preterm infant with hemodynamically significant PDA \< 32 weeks, birth weight \< 1500g, and \> 72 hours of age

Device: NONIN SenSmart model X-100 near- infrared spectrometer

Interventions

for to measure cerebral (cSO2) and renal (rSO2 ) regional tissue oxygen saturation on the day after echocardiography was done. The sensors were placed on the right/left forehead and the right/left lateral posterior flank

Also known as: GE LOGIQ S8 XDclear 2.0 ultrasoud
group1group2group3

Eligibility Criteria

Age22 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants with gestation age of \< 32 weeks, birth weight \< 1500g, \> 72 hours of age, will have NIRS monitors placed to measure cerebral and renal regional tissue oxygenation.

You may qualify if:

  • preterm infants with gestation age of \< 32 weeks
  • birth weight \< 1500g
  • \> 72 hours of age.

You may not qualify if:

  • cardiovascular, renal, cerebral congenital defects,
  • confirmed sepsis,
  • no parental consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vilnius University Santaros Klinikos Neonatology Center

Vilnius, 08406, Lithuania

Location

Related Publications (1)

  • Navikiene J, Virsilas E, Vankeviciene R, Liubsys A, Jankauskiene A. Brain and renal oxygenation measured by NIRS related to patent ductus arteriosus in preterm infants: a prospective observational study. BMC Pediatr. 2021 Dec 9;21(1):559. doi: 10.1186/s12887-021-03036-w.

MeSH Terms

Conditions

Premature BirthDuctus Arteriosus, Patent

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Augustina Jankauskiene, MD

    Vilnius University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2020

First Posted

March 4, 2020

Study Start

November 9, 2017

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

January 4, 2023

Record last verified: 2021-03

Locations